In this issue:
Upgrading HER2 targeting with zanidatamab promising for HER2+ GEA
dMMR GEA is responsive to ICI-based therapy
Preoperative ctDNA detection enhances risk stratification in early-stage OSCC
Oesophagectomy prolongs adjusted life expectancy vs active surveillance
Outcomes in patients with oesophageal melanoma
Survival benefit with robot-assisted vs conventional oesophagectomy in OSCC
FGFR2b overexpressed in more than two-thirds of advanced gastric/GEJ cancers
Telisotuzumab adizutecan promising for pre-treated advanced GEA
Nivolumab + chemo durably improves outcomes in advanced GEA
Study aims to clarify surgical timing post-neoadjuvant therapy
Please login below to download this issue (PDF)